Castrate-Resistant-Prostate-Cancer-Treatment-–-Ac225-PSMA-Therapy-Targeted-Alpha-Therapy nuclearmedicinetherapy.in

ajay sharma 4 months ago in Health

For CRPC patients receiving Ac225 PSMA Therapy, there cycles of treatments at intervals of two months are administered. And depending upon the response to therapy, further salvage cycles may be given.